NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and its subsidiary, Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM) as per the terms of the LOI described in the form 8-k filed on March 5, 2009.
